CAPTRUST Financial Advisors
PRPH

CAPTRUST Financial Advisors’s ProPhase Labs PRPH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$13K – 3530
2022
Q2 		$13K Hold
100
– – ﹤0.01% 3614
2022
Q1 		$7K Hold
100
– – ﹤0.01% 3987
2021
Q4 		$7K Hold
100
– – ﹤0.01% 3919
2021
Q3 		$5K Hold
100
– – ﹤0.01% 3953
2021
Q2 		$6K Sell
100
-150
-60% -$8.43K ﹤0.01% 3793
2021
Q1 		$18K Buy
+250
New +$24K ﹤0.01% 3076

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CAPTRUST Financial Advisors's PRPH Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of ProPhase Labs (PRPH) in Q3 2022, closing a stake of 100 shares — an estimated $13K sold.

CAPTRUST Financial Advisors first reported a position in PRPH in Q1 2021 and held it in 6 quarters. The position peaked at $18K in Q1 2021. 43 funds tracked by Wall St. Rank hold PRPH as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining ProPhase Labs position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 100 ProPhase Labs shares in Q3 2022, an estimated $13K.
  • CAPTRUST Financial Advisors first reported a position in ProPhase Labs in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's ProPhase Labs position peaked at $18K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.